Addgene: pLKO1-shYAP1 Citations

pLKO1-shYAP1 Citations (14)

Originally described in: TEAD mediates YAP-dependent gene induction and growth control.
Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL Genes Dev. 2008 Jul 15. 22(14):1962-71. PubMed Journal

Articles Citing pLKO1-shYAP1

Showing 1 to 10 of 14 entries

Show entries

Search table:

Articles
"Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2". Bulos ML, Grzelak EM, Li-Ma C, Chen E, Hull M, Johnson KA, Bollong MJ. bioRxiv. 2023 Apr 19:2023.04.19.537449. doi: 10.1101/2023.04.19.537449. Preprint. PubMed
The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1. Han H, Nakaoka HJ, Hofmann L, Zhou JJ, Yu C, Zeng L, Nan J, Seo G, Vargas RE, Yang B, Qi R, Bardwell L, Fishman DA, Cho KWY, Huang L, Luo R, Warrior R, Wang W. Nat Cell Biol. 2022 Jan;24(1):74-87. doi: 10.1038/s41556-021-00813-8. Epub 2022 Jan 13. PubMed
Autophagy-mediated negative feedback attenuates the oncogenic activity of YAP in pancreatic cancer. Sun T, Peng H, Mao W, Ma L, Liu H, Mai J, Jiao L. Int J Biol Sci. 2021 Aug 21;17(13):3634-3645. doi: 10.7150/ijbs.61795. eCollection 2021. PubMed
The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2. Yang WH, Lin CC, Wu J, Chao PY, Chen K, Chen PH, Chi JT. Mol Cancer Res. 2021 Jun;19(6):1005-1014. doi: 10.1158/1541-7786.MCR-20-0534. Epub 2021 Mar 11. PubMed
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin. Sun T, Mao W, Peng H, Wang Q, Jiao L. Cell Oncol (Dordr). 2021 Jun;44(3):689-699. doi: 10.1007/s13402-021-00595-z. Epub 2021 Mar 3. PubMed
Chronic GPER1 Activation Protects Against Oxidative Stress-Induced Cardiomyoblast Death via Preservation of Mitochondrial Integrity and Deactivation of Mammalian Sterile-20-Like Kinase/Yes-Associated Protein Pathway. Imam Aliagan A, Madungwe NB, Tombo N, Feng Y, Bopassa JC. Front Endocrinol (Lausanne). 2020 Oct 19;11:579161. doi: 10.3389/fendo.2020.579161. eCollection 2020. PubMed
Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases. Park J, Kim DH, Shah SR, Kim HN, Kshitiz, Kim P, Quinones-Hinojosa A, Levchenko A. Nat Commun. 2019 Jun 26;10(1):2797. doi: 10.1038/s41467-019-10729-5. PubMed
Hippo signaling dysfunction induces cancer cell addiction to YAP. Han H, Yang B, Nakaoka HJ, Yang J, Zhao Y, Le Nguyen K, Bishara AT, Mandalia TK, Wang W. Oncogene. 2018 Dec;37(50):6414-6424. doi: 10.1038/s41388-018-0419-5. Epub 2018 Aug 1. PubMed
Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner. Lee Y, Kim NH, Cho ES, Yang JH, Cha YH, Kang HE, Yun JS, Cho SB, Lee SH, Paclikova P, Radaszkiewicz TW, Bryja V, Kang CG, Yuk YS, Cha SY, Kim SY, Kim HS, Yook JI. Nat Commun. 2018 Jun 12;9(1):2301. doi: 10.1038/s41467-018-04757-w. PubMed
LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism. Zheng X, Han H, Liu GP, Ma YX, Pan RL, Sang LJ, Li RH, Yang LJ, Marks JR, Wang W, Lin A. EMBO J. 2017 Nov 15;36(22):3325-3335. doi: 10.15252/embj.201797609. Epub 2017 Sep 28. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.